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Omega-3 fatty acidAbstract The hypolipidemic effect of fat spreads containing ﬂaxseed oil (rich plant source of long-
chain omega-3 polyunsaturated fatty acid) represents the aim of the present study. Such effect was
biologically evaluated through assessment of four biochemical parameters that reﬂect the blood
serum lipid proﬁle, namely total cholesterol, low- and high-density lipoproteins and triglyceride
levels during a feeding experiment for 8 successive weeks using male albino rats. Eight fat spreads
containing 20%, 40%, 60% and 80% total fat were used; of these, four spreads were formulated
using palm and ﬂaxseed oils while the other four treatments were prepared by palm and soybean
oils at the same concentrations. Results showed that fat spreads containing ﬂaxseed oil exerted
reducing effect on total cholesterol, LDL levels, TC/HDL and LDL/HDL ratios at higher rates
compared with those containing soybean oil or pharmaceutical product especially after 8 weeks
of feeding experiment. Levels of HDL in animals administered the studied fat spreads were lowered
at signiﬁcant to insigniﬁcant different rates. Flaxseed oil exerted its beneﬁcial effect when it was
incorporated into formulation at high amounts since G6 (FPB3, containing 29.5% ﬂaxseed oil)
and G8 (FPB4, containing 39% ﬂaxseed oil) animal groups exerted higher/comparative levels of
HDL after 8 weeks of feeding compared to the initial concentration. Concerning triglycerides levels,
all studied groups (except G8, FPB4) and controls showed signiﬁcant higher levels at the end of
feeding experiment compared to initial concentration. On the other hand, animals received the high-
est% of ﬂaxseed oil (G8, FPB4) exerted its healthy effect as triglycerides levels were decreased from
104.3 mg/dL at zero time to 92.7 mg/dL after 4 weeks of feeding with decreasing rate of 11.1%,
another reducing effect was noted after 8 weeks as triglycerides levels were signiﬁcantly decreased
to 79.7 mg/dL (decreasing rate of 23.6%).
ª 2014 Production and hosting by Elsevier B.V. on behalf of Faculty of Agriculture, Ain Shams
University. Open access under CC BY-NC-ND license.Introduction
Hyperlipidemia, also known as hyperlipoproteinemia or
dyslipidemia, is an abnormal elevation of lipid levels in the
blood stream. These lipids include cholesterol, cholesterol
18 M.A. El-Waseif et al.compounds, phospholipids and triglycerides, all carried in
blood as large molecules called lipoproteins. There are three
types of hyperlipidemia namely hyperlipoproteinemia (ele-
vated levels of lipoprotein in blood), hypercholesterolemia
(high cholesterol) and hypertriglyceridemia (high triglycerides
level in blood). Hyperlipidemia affects lipid production, trans-
portation in blood stream and/or deposition in body cell
(Carrero et al., 2004; Sies et al., 2005).
Increased consumer awareness of diet and health has
resulted in higher demand for functional foods. In fat spreads
market, two trends are emerging, i.e. enrichment with omega-3
fatty acids and the reduction in trans fatty acids (TFAs). How-
ever, there are currently signiﬁcant technical gaps in the effec-
tive delivery of both omega-3 fatty acids and spreads which are
genuinely low in trans fatty acids (Timon, 2010). The spread
fat industry is working diligently in creating new varieties of
spread fats that will produce more healthful fat.
Intake of high amounts of TFAs has been positively corre-
lated with increased risk of coronary heart disease, inﬂamma-
tion, and cancer (Pande and Akoh, 2013). The major dietary
sources of TFAs are products formulated with partially hydro-
genated fats such as margarines, shortenings, bakery products,
and fast foods (Wahle and James, 1993; Willet et al., 1993).
The oils rich in polyunsaturated fatty acids (PUFAs) cause a
decrease in ‘‘bad’’ cholesterol and triglycerides concentrations.
Also, the omega-3 (x-3) fatty acids (such as linolenic acid) in
oils can increase the level of circulating good cholesterol
(Khan et al., 2010).
Ng et al. (1992) and Choudry et al. (1995) declared that
palm olein and olive oil have similar beneﬁcial cholesterol
modulating effects in protecting humans against cardiovascu-
lar diseases. Palm olein (rich in both fatty acids C16:0 and
C18:1 represents about 40% and 43% of total fatty acids,
respectively) and olive oil (rich in C18:1 fatty acids, about
77% of total fatty acids) have comparable effects on total cho-
lesterol, low- and high-density lipoproteins cholesterol (LDL
and HDL) as well as LDL/HDL ratio.
Omega 3-fatty acids have a high nutritional status, its con-
sumption has been reported by Tou et al. (2011) to improve
health by reducing the risk of cardiovascular disease, obesity,
diabetes, inﬂammation, and several neurological diseases.
But their use in food products is limited due to their suscepti-
bility to lipid oxidation (Choo et al., 2007). Also, ﬁsh oil (as
source of omega-3) incorporation into fat spreads (especially
at high %) resulted in increasingly ﬁshy ﬂavor and decreased
sensory quality (Kolanowski et al., 2004).
Lipid ﬂaxseed composition makes it an important source of
omega 3 fatty acids, especially a-linolenic acid (ALA) which
may constitute up to 52% (Gutie´rrez et al., 2010) and
59.02% (El-Waseif et al., 2013) of the total fatty acids.
Morris (2006) stated that ﬂaxseed oil is a potentially vegetable
important source of omega-3 as it is relatively stable to oxida-
tion compared to ﬁsh oils.
Consumption of food products (such as fat spreads)
enriched with ﬂaxseed oil as a source of omega-3 PUFA repre-
sents an easy delivery system of such fatty acids into the
human body and signiﬁcantly improves the level and proﬁle
of PUFA in the diet and in human body tissues. In addition,
Grune et al. (2001) and Grundt et al. (2003) demonstrated that
the bioavailability of omega-3 from enriched intake was com-
parable with the bioavailability of the acids from capsule
supplements.As recommended by the American Heart Association,
beneﬁcial health effects could be gained for people with high
triglycerides (blood fat) when they were supplemented with
1.5–3 g of ﬂaxseed oil per day, the increased use of omega
x-3 fatty acids is a powerful example of one such nutritional
therapeutic strategy that may produce signiﬁcant cardiovascu-
lar beneﬁts (Kris-Etherton et al., 2003; Rodriguez et al., 2010).
The present study was designed to evaluate the effect of
oral ingestion of edible spreadable fats containing ﬂaxseed
oil (at four different concentrations) on blood serum lipid pro-
ﬁle. Four parameter levels, namely total cholesterol, HDL,
LDL and triglycerides during feeding experiment for 8 weeks
using albino rats, were measured.
Materials and methods
Materials
Reﬁned, bleached and deodorized palm and soybean oils were
obtained from Arma Food Industries, 10th of Ramadan City,
Egypt. Flaxseeds (Linum usitatissimum L.), variety Sakha 1,
free from garden cress and weed seeds were obtained from
Fiber Crops Research Section, Field Crops Research Institute,
Agriculture Research Center, Giza, Egypt. Other materials
used as additives including stabilizers (corn starch, sodium
alginate and whey protein powder); emulsifying agents
(skimmed milk powder, soybean lecithin and glycerol monos-
tearate); antioxidant (ascorbyl palmitate); preservative (potas-
sium sorbate) and ﬂavor (butter ﬂavor) were used in
formulation of fat spreads.
Methods
Extraction of ﬂaxseed oil
Flaxseed oil was extracted from crushed seeds using a hydrau-
lic press (10,000 Lb/inch2 for 1 h at room temperature) as
described by Ustun et al. (1990). The resultant oil was ﬁltered
through a ﬁne cloth, ﬁlled in dark brown bottles and stored at
deep freezing temperature (18 C) until use.
Preparation of fat spreads
Eight fat spreads (blends) containing 20%, 40%, 60% and 80%
total fat were formulated, according to procedures of Cheng
et al. (2008) and Lumor et al. (2010) with minor modiﬁcations.
El-Waseif et al. (2013), in previous work, described the details
of formulation procedure followed. Four treatments were for-
mulated using palm and ﬂaxseed oils, the other four treatments
contained palm and soybean oils (as a control treatments).
Biochemical experiment
Animals and negative control treatment
Sixty-six adults male albino rats (body weight 120–140 g);
obtained from the farm of National Organization for Drug
Control and Research, Giza, Egypt; were housed in screen bot-
tomed aluminum cages in rooms maintained at 25 ± 1 C with
alternating cycles of light and dark of 12 h duration. The rats
were fed on the control diet basal diet (composed of; g/100 g
diet; casein 10.0, cotton seed oil 5.0, salt mixture 4.0, vitamin
mixture 1.0 and maize starch as carbohydrate source, 80.0).
Hypolipidemic effect of fat spread containing ﬂaxseed oil 19Salt mixture was consisted of (g/1Kg): CaCo3 (543.0),
MgCo3 (25.0) MgSo4 (16.0) NaCl (69.0) KCl (112.0) KH2Po4
(212.0) FePo4 4H2O (20.50) KI (0.08) MnSo4 (0.35) Naf
(1.00) Al2(So4)3 K2So4 (0.17) Cusou (0.90) (Mendel and
Wakeman, 1937). Vitamin mixture (Campell, 1961) composed
of (per ech kg of basal diet): vit. A (200 I.U.), vit. D (100
I.U.), vit. E (10 I.U.), vit. K (0.5 mg), choline chloride
(200 mg), inositol (25 mg), niacin (4 mg) thiamine (0.5 mg),
riboﬂavin (1.0 mg), pyridoxine (0.4 mg), pantothenic (0.4) P.
amino benzoic acid (10.0 mg), B12 (2.0 mg), biotin
(0.02 mg) folic acid (0.02 mg) and cellulose to make 1 kg.
The diet was freshly prepared every week and was stored in
a refrigerator at 10 C.
After seven consecutive days of feeding on basal diet
(adaptation period), the blood samples (ve control treat-
ment) were withdrawn from retro bulbar venous plexus of each
rat following the procedure of Schermer (1967). Collected
blood sample was placed in a dry and clean centrifuge tube
and allowed to clot (undisturbed) for 1–2 h at 37 C. The
serum was removed using a Pasteur pipette and centrifuged
for 10 min. at 3000 r.p.m. to remove any suspended red blood
cells. The clean nonhemolyzed supernatant serum was pipetted
into a Wassermann tube and kept at freezing temperature
(18 C) until analysis.
Induction of hyperlipidemia
According to Gone et al. (1989), hyperlipidemia in rats was
done by feeding on an animal high fat diet contained 20%
coconut oil and 1% cholesterol, the used high fat diet con-
tained cholic acid (0.5%) to enhance the central absorption
of lipids. After 2 months of feeding, the occurrence of hyper-
lipidemia was assessed by determining the lipid parameters in
blood serum of treated animals.
Feeding experiment
Hyperlipidemic rats were randomly classiﬁed into eleven equal
groups (each comprises 6 rats) in addition to the negative con-
trol group. Rats were treated for 8 weeks by nine different for-
mulas as follows:
1. Negative control (basal diet) (ve).
2. Positive control group (+ve).
3. SPB1 = Soybean-Palm oils blend (20%).
4. FPB1 = Flaxseed-Palm oils blend (20%).
5. SPB2 = Soybean-Palm oils blend (40%).
6. FPB2 = Flaxseed-Palm oils blend (40%).
7. SPB3 = Soybean-Palm oils blend (60%).
8. FPB3 = Flaxseed-Palm oils blend (60%).
9. SPB4 = Soybean-Palm oils blend (80%).
10. FPB4 = Flaxseed-Palm oils blend (80%).
11. Pharmaceutical product (contains 1000 mg of ﬁsh oil;
EPA (Eicosapentaenoic acid), C20:5 omega-3 and DHA
(Docosahexaenoic acid), C22:6 omega-3, 30%).
Fat spreads were given orally to the ratat a daily dose of
(1.8 g/kg of body weight) throughout the feeding period
(8 weeks). During such period, rats were individually weighted
and blood samples were collected at time intervals of 0, 4 and
8 weeks.Determination of serum lipid parameters
According to Tzang et al. (2009) serum lipid parameters,
namely serum total cholesterol (TC), triacylglycerol (TAG),
and high density lipoprotein cholesterol (HDL) were measured
by using commercial kits (Randox Laboratories Ltd., Antrim,
UK, BT294QY). For HDL, serum was precipitated by addi-
tion of phosphotungstic acid in the presence of magnesium
ions. After centrifugation (3000 g for 10 min), the cholesterol
concentration in HDL fraction was determined by using the
TC commercial kit (Randox Laboratories Ltd., Antrim, UK,
BT294QY). Those methods are based on measuring of colored
end-products at 500 nm. LDL concentration was calculated
according to the formula of Beena and Prasad (1997).
Statistical analysis
One-way analysis of variance using SPSS 16.0 for windows
was performed on all experimental data sets. Post-hoc multiple
comparisons were carried out by Duncan analysis to determine
signiﬁcant differences between sample means at 5% level.Results and discussion
When lipid levels in the blood serum were abnormally ele-
vated, it is important to bring such levels under control. This
is done more safely with changing dietary habits by increasing
the consumption of diets low in total fat, saturated and choles-
terol. The present study was aimed to evaluate the inﬂuence of
ﬂaxseed oil supplemented dietary on experimentally induced
hyperlipidemia in rats. Eight formulated fat spreads containing
different percentages of total fat %s (namely 20%, 40%, 60%
and 80%) were tested as lowering agents for hyperlipidemia in
the rats. Tested animals were orally ingested the fat spread at
dose equivalent to the dose recommended by Kris-Etherton
et al. (2003) for human beings (1.5–3.0 g/day). The effect of
each spread was evaluated by assessment of total cholesterol,
HDL, LDL and triglycerides concentrations in blood serum
of manipulated animals in comparison with pharmaceutical
preparation of omega-3.
Body weight
The hyperlipidemic rats and the manipulated groups were
weighted at the beginning (initial weight) and after 8 weeks
of feeding. The results are summarized in Table 1.
Tested rats showed varied values of average initial weight
ranged between 125.3 and 154.3 g (Table 1). Signiﬁcant
(P< 0.05) increases in body weight of all studied rats (at vary-
ing %s) were observed since their average values were reached
to 157.0–187.5 g at the end of feeding experiment.
In comparison with the initial body weight, average weight
of hyperlipidemic fed rats (+ control, G10) was increased by
21.64% at the end of feeding experiment. While the negative
control group (G11) exhibited an increase by only 5.51% in
the same period. Simultaneously, weight of hyperlipidemic
and manipulated rat groups was increased signiﬁcantly at dif-
ferent levels (18.34–35.0%) as a result of applying the feeding
program. Positive control group (G10) as well as rats belonged
to G9 group (received the pharmaceutical product contains
ﬁsh oils, EPA and DHA by 81 mg 1 day as recommended by
Table 1 Average body weight gain of rats fed as affected by fat spread formulations for 8 weeks.
Treatment Initial body weight* (g) Body weight after 8 weeks* (g) Body weight gain (%)
Negative control () (G11) 148.8 ± 6.01b 157.0 ± 5.51a 5.51
Positive control (+) (G10) 129.4 ± 5.17b 157.4 ± 5.17a 21.64
Pharmaceutical product (G9) 152.7 ± 1.60b 180.7 ± 1.60a 18.34
SPB1 (G1) 148.6 ± 10.48b 182.3 ± 10.27a 22.68
FPB1 (G2) 141.0 ± 13.31b 173.5 ± 10.71a 23.05
SPB2 (G3) 154.3 ± 11.62b 187.5 ± 9.91a 21.52
FPB2 (G4) 149.7 ± 6.86b 177.2 ± 19.83a 18.37
SPB3 (G5) 130.0 ± 11.22b 175.5 ± 5.73a 35.00
FPB3 (G6) 125.3 ± 10.01b 166.4 ± 8.12a 32.80
SPB4 (G7) 126.0 ± 17.84b 166.9 ± 11.58a 32.46
FPB4 (G8) 125.3 ± 10.09b 162.1 ± 13.42a 29.37
Values with different small letters in the same row are signiﬁcantly different (P< 0.05).
% was calculated relative to the initial.
SPB1 = Soybean-Palm oils blend (20%).
SPB2 = Soybean-Palm oils blend (40%).
SPB3 = Soybean-Palm oils blend (60%).
SPB4 = Soybean-Palm oils blend (80%).
FPB1 = Flaxseed-Palm oils blend (20%).
FPB2 = Flaxseed-Palm oils blend (40%).
FPB3 = Flaxseed-Palm oils blend (60%).
FPB4 = Flaxseed-Palm oils blend (80%).
* Each value represents the mean weight of 6 rats ± SD.
20 M.A. El-Waseif et al.its pamphlet) increased in weight by 21.64 and 18.34%, respec-
tively, while rats of other groups fed on fat spreads showed
comparable higher %s (18.37–35.0%). Among rat groups
received tested fat spreads, G5 (SPB3) group exerted the high-
est increase % (35.00%). On the other hand, the lowest
increase level was found for G4(FPB2) group (18.37%).
In general, body weight gain of rat groups fed on high fat
diet was increased at higher levels compared to those fed on
basal diet. Rats administered fat spreads containing ﬂaxseed
oil showed somewhat less body weight gain %s compared to
the corresponding groups fed on spreads formulated with soy-
bean oil (except for those fed on spreads of 20% total fat).
Vijaimohan et al. (2006) found similar conclusions as they
reported that using high fat diet caused high body weight gain
compared to basal diet. Also, using ﬂaxseed oil in the formu-
lation of spreads (compared to soy bean oil) caused signiﬁcant
lowering effect on body weight gain. Body weight was
increased (at the end of the feeding experiment) by 18.37%,
32.80% and 29.37% when FPB2, FPB3 and FPB4 respec-
tively, were used for feeding while the corresponding spreads
(SPB2, SPB3 and SPB4) showed values of 21.52%, 35.0%
and 32.38% respectively, (Table 1). The same results reveal
that levels of body weight increase were high in rat groups
fed on fat spreads containing the highest total fat% (60%
and 80%) than groups received fat spread of less total fat con-
tent (20% and 40%). These observations could be related to
the high content of x-3 fatty acid (ALA) in fat spreads of high
fat content as reported by Vijaimohan et al. (2006) and Tzang
et al. (2009).
Serum lipid parameter
Serum lipid proﬁle (levels of total cholesterol, LDL, HDL and
triglycerides as mg/dL in blood serum) as affected by oral inges-
tion of the eight formulated fat spreads for 8 successive weeks
was studied, the obtained results were recorded in Table 2.Total cholesterol
As a result of feeding experiment, total cholesterol concentra-
tion was increased insigniﬁcantly in the negative control group
(G11). On the other hand, signiﬁcant decrease was noted in the
treatments of positive control (G10) and G9 group that
received the pharmaceutical product. Also, rat groups manip-
ulated with tested fat spreads showed signiﬁcant (P< 0.05)
lower total cholesterol concentration after 8 weeks of feeding
program. Concentration reducing was happened at different
rates and was pronounced than that showed by G9 group (in
most cases).
Fat spreads containing ﬂaxseed oil exerted reducing effect
of total cholesterol level at higher rates compared with those
containing soybean oil, especially at the end of feeding
experiment. G7 and G8 groups (administered SPB4 and
FPB4 spreads) exhibited concentrations of 94.8 ± 2.1 and
117.5 ± 8.5 mg/dL, respectively, at the beginning of the exper-
iment and decreased to 80.2 ± 4.8 and 70.3 ± 1.0 mg/dL,
respectively (decreasing rates of 15.40% and 40.17%, respec-
tively) after 8 weeks of feeding experiment (Table 2).
LDL
At the end of the feeding experiment, the bad cholesterol
(LDL) concentration in the negative control (G11) group
was increased signiﬁcantly as a result of feeding on basal diet;
while in G9 and G10 (positive control) groups, the level of the
same parameter was lowered signiﬁcantly after 8 weeks of
feeding (P< 0.05). When the eight fat spreads were adminis-
tered orally to tested rats, signiﬁcant decreases were observed
for groups up to 4 weeks of feeding. Furthermore, another sig-
niﬁcant reducing effect (at varied %s) was noted during the
period from the fourth to the eighth week of feeding.
The same results (Table 2) declared that incorporation of
ﬂaxseed oil into the formulated fat spreads exerted its marked
lowering effect on LDL concentration in blood serum of tested
rats. This ﬁnding was observed in comparison with either
Table 2 Effect of fat spreads on the blood serum lipid parameters of hyperlipidemic male albino rats.
Treatment
schedule (N= 6)
Total cholesterol mg/dL* LDL mg/dL* HDL mg/dL* Triglycerides mg/dL*
0 Time 4 weeks 8 weeks 0 Time 4 weeks 8 weeks 0 Time 4 weeks 8 weeks 0 Time 4 weeks 8 weeks
G11 () 68.3 ± 1.6a 68.5 ± 1.9a 70.0 ± 1.8a 23.1 ± 1.1b 24.8 ± 1.3b 27.1 ± 1.1a 32.2 ± 2.1a 30.4 ± 1.5ab 29.3 ± 1.2b 64.8 ± 1.5b 66.7 ± 1.5ab 68.0 ± 2.1a
G10 (+) 114.3 ± 6.12a 108.7 ± 2.1b 107.7 ± 2.3b 57.1 ± 3.3a 52.0 ± 5.5b 50.5 ± 4.3c 34.0 ± 2.1a 30.4 ± 1.8b 30.3 ± 1.7b 116.0 ± 13.3b 131.3 ± 14.3ab 134.3 ± 14.4a
G9 (Ph) 110.3 ± 8.5a 91.7 ± 6.8b 79.3 ± 5.2c 59.9 ± 2.4a 39.1 ± 2.3b 25.9 ± 5.4c 31.8 ± 2.9a 30.5 ± 4.8a 28.5 ± 6.8a 93.0 ± 3.0c 110.5 ± 7.7b 124.7 ± 14.7a
G1 (SPB1) 107.3 ± 5.4a 88.8 ± 4.3b 85.5 ± 16.7b 61.3 ± 1.6a 35.2 ± 5.8b 26.8 ± 6.0c 31.1 ± 1.3a 29.4 ± 2.5a 26.2 ± 6.0a 74.3 ± 8.6c 121.2 ± 8.1b 162.8 ± 17.5a
G2 (FPB1) 123.0 ± 13.3a 102.1 ± 11.1b 65.5 ± 6.1c 71.7 ± 4.1 a 43.3 ± 2.3b 28.4 ± 4.8c 32.7 ± 2.9a 31.3 ± 3.2a 28.0 ± 4.8a 94.7 ± 0.82b 137.5 ± 19.0a 156.5 ± 19.9a
G3 (SPB2) 116.3 ± 19.3a 102.8 ± 12.8ab 95.0 ± 14.2b 65.3 ± 4.4a 49.7 ± 3.1b 41.5 ± 4.3c 35.3 ± 1.6a 33.6 ± 0.9a 29.2 ± 3.3b 78.7 ± 10.8b 97.3 ± 13.8ab 121.7 ± 38.5a
G4 (FPB2) 119.8 ± 6.0a 99.5 ± 4.9b 82.0 ± 3.9c 62.8 ± 2.4a 43.0 ± 2.0b 29.4 ± 5.8c 34.7 ± 1.6a 32.7 ± 2.6ab 28.0 ± 6.4b 111.7 ± 17.2a 119.0 ± 16.7a 124.3 ± 18.8a
G5 (SPB3) 115.8 ± 2.1a 96.2 ± 1.7b 95.0 ± 23.9b 56 ± 1.9a 33.0 ± 1.4b 36.4 ± 3.0c 39.8 ± 2.3a 36.0 ± 2.1b 28.8 ± 2.5c 99.0 ± 2.4b 135.8 ± 30.9a 149.2 ± 36.9a
G6 (FPB3) 101.7 ± 3.2a 84.5 ± 2.6b 73.2 ± 13.9c 51.1 ± 2.3a 30.6 ± 1.6b 18.2 ± 1.8c 31.0 ± 1.8a 32.7 ± 1.9a 32.8 ± 1.8a 98.0 ± 11.6b 106.2 ± 2.1ab 113.3 ± 8.0a
G7 (SPB4) 94.8 ± 2.1a 84.5 ± 5.9b 80.2 ± 4.8b 41.6 ± 2.4a 30.2 ± 4.0b 24.3 ± 4.2c 34.0 ± 2.6a 33.9 ± 4.2a 34.2 ± 4.6a 94.5 ± 7.7b 102.0 ± 5.2ab 108.5 ± 8.0a
G8 (FPB4) 117.5 ± 8.5a 92.8 ± 13.5b 70.3 ± 1.0c 60.6 ± 3.4a 38.6 ± 3.5b 18.9 ± 2.2c 36.0 ± 2.8a 35.7 ± 3.3a 35.5 ± 3.6a 104.3 ± 10.5a 92.7 ± 8.8ab 79.7 ± 12.2b
Values with different small letters in the same row are signiﬁcantly different (P< 0.05).
SPB1 = Soybean-Palm oils blend (20%).
SPB2 = Soybean-Palm oils blend (40%.
SPB3 = Soybean-Palm oils blend (60%).
SPB4 = Soybean-Palm oils blend (80%).
Ph = Pharmaceutical product.
FPB1 = Flaxseed-Palm oils blend (20%).
FPB2 = Flaxseed-Palm oils blend (40%).
FPB3 = Flaxseed-Palm oils blend (60%).
FPB4 = Flaxseed-Palm oils blend (80%).
* (M± S.D) =Mean ± Std. Deviation.
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Table 3 TC/HDL and LDL/HDL ratios of blood serum of male albino rats as affected by feeding fat spreads.
Treatment TC/HDL ratio LDL/HDL ratio
0 Time 4 weeks 8 weeks 0 Time 4 weeks 8 weeks
G11 () 2.12 2.25 2.38 0.68 0.73 0.82
G10 (+) 3.36 3.75 3.55 1.64 1.73 1.64
G9 (Ph) 3.47 3.01 2.78 1.85 1.31 0.91
G1 (SPB1) 3.45 3.26 3.02 1.93 1.49 1.09
G2 (FPB1) 3.77 3.26 2.34 2.00 1.38 0.77
G3 (SPB2) 3.29 3.25 3.06 1.85 1.60 1.45
G4 (FPB2) 3.45 3.04 2.93 1.74 1.34 1.02
G5 (SPB3) 2.91 2.67 3.30 1.63 1.32 1.28
G6 (FPB3) 3.28 2.58 2.23 1.60 0.99 0.62
G7 (SPB4) 2.79 2.49 2.34 1.29 1.11 0.76
G8 (FPB4) 3.26 2.60 1.98 1.25 0.80 0.54
SPB1 = Soybean-Palm oils blend (20%).
FPB1 = Flaxseed-Palm oils blend (20%).
SPB2 = Soybean-Palm oils blend (40%).
FPB2 = Flaxseed-Palm oils blend (40%).
SPB3 = Soybean-Palm oils blend (60%).
FPB3 = Flaxseed-Palm oils blend (60%).
SPB4 = Soybean-Palm oils blend (80%).
FPB4 = Flaxseed-Palm oils blend (80%).
Ph = Pharmaceutical product.
22 M.A. El-Waseif et al.soybean oil or the pharmaceutical product tested. Using
spreads containing ﬂaxseed oil in feeding causing reducing of
LDL level by 52.40–67.17% of the initial concentration
compared to 34.81–52.5% and 32.37–55.93% for spreads con-
tained soybean oil and pharmaceutical product, respectively.
HDL
The concentration of HDL (good cholesterol) in blood serum
of rats belonged to G11, G10 and G9 groups (negative, posi-
tive controls and group received the pharmaceutical product,
respectively) was reduced gradually after feeding for 8 weeks
with decreasing levels of 9.0–10.88% of the initial concentra-
tion. Also, level of HDL in animals orally ingested the studied
fat spreads diminished at signiﬁcant to insigniﬁcant different
rates. Flaxseed oil exerted its beneﬁcial effect when it was uti-
lized in formulation at high amounts since G6 (FPB3, contain-
ing 29.5% ﬂaxseed oil) and G8 (FPB4, containing 39%
ﬂaxseed oil) exerted higher/comparative levels of HDL after
8 weeks of feeding compared to the initial concentration,
(Table 2).
Triglycerides
Compared to the initial concentration of triglycerides in
blood serum, all studied rat groups (including the control
with exception of G8 group, FPB4) showed signiﬁcant higher
levels at the end of feeding experiment (Table 2). On the
other hand, fat spread treatment that contained the highest
amount of ﬂaxseed oil (39%) (G8, FPB4), compared of the
other spreads containing ﬂaxseed oil, exerted its healthy effect
of triglycerides level since it decreased from 104.3 ± 10.5 mg/
dL at the beginning of feeding experiment to 92.7 ± 8.8 mg/
dL after four weeks of feeding with decreasing rate of
11.12%. Moreover, another reducing effect was noted after
8 weeks of feeding where triglycerides concentration was
signiﬁcantly diminished to 79.7 ± 12.2 mg/dL with decreas-
ing rate of 23.58% (Table 2).In general, the effects of ﬂaxseed and ﬂaxseed oil supple-
mentation on plasma lipid have been controversial. Arjmandi
et al. (1998) concluded that ﬂaxseed oil has been shown to have
inconsistent results with a few studies ﬁnding a modest reduc-
tion in triglycerides with large doses, but most with no effects.
While, Tzang et al. (2009) showed hypocholesterolaemic effect
of ﬂaxseed oil compared to coconut oil and butter. Also,
plasma triglycerides and cholesterol concentration in serum
blood of mice were declined as the result of feeding diet con-
taining ﬂaxseed oil (Riediger et al., 2008). Cunnane et al.
(1993) and Craig (1999) cited that ﬂaxseed and its oil have
decreasing effect in total cholesterol, LDL, LDL/HDL. On
the other hand, Lucas et al. (2004) found that triglyceride con-
centration was higher in the ﬂax-fed hamsters.
TC/HDL and LDL/HDL ratio
Results in Table 3 shows the effect of feeding rats on different
fat spreads upon TC/HDL and LDL/HDL ratios. Values of
the two calculated ratios were increased for positive (G10)
and negative (G11) control animals. On the other hand, the
corresponding values for rat group received the pharmaceuti-
cal product (G9) were decreased by 19.88% and 50.81%,
respectively at the end of feeding experiment (after 8 weeks).
Also, rat groups administered the different tested fat spreads
exerted the same trend for the two calculated ratios (at varied
rates). After 4 weeks of feeding experiment; TC/HDL ratio
was decreased by 1.21–21.34% of its initial value, while
LDL/HDL ratio was also diminished at relatively higher rates
(13.51–38.12%). The same results declared that values of the
calculated two ratios were gradually reduced parallel in man-
ner with feeding experiment weeks.
In other words, the least values of the two calculated ratios
were detected at the end of feeding experiment for all groups
received the tested fat spreads. After 8 weeks of feeding, TC/
HDL and LDL/HDL ratios were decreased by 6.99–39.26
and 21.47–61.50%, respectively.
Hypolipidemic effect of fat spread containing ﬂaxseed oil 23Spreads containing ﬂaxseed oil (especially at high levels,
60% and 80% total fat) exhibited their appreciable effects
compared to those containing soybean oil. Values of TC/
HDL ratio were reduced by 15.07–38.26% and 5.51–16.13%
of its initial values (for ﬂaxseed and soy bean oils formulated
spreads), respectively, at the end of feeding experiment.
LDL/HDL ratio showed the same trend (at higher %s) as its
values were lowered by 41.38–61.50% and 21.47–43.52% for
the same spreads, respectively, and at the same period of
experiment. These ﬁndings were found in accordance with
the results of Vijaimohan et al. (2006). Such observed reducing
effects could be considered as one of the healthy beneﬁts of
alphalinolenic acid (ALA) on plasma lipids, so ﬂaxseed oil
(rich of ALA) could be used as a source of ALA to modify
plasma lipids (Xu et al., 2012; Cunnane et al., 1993).
Flaxseed oil is a one of the richest sources of the plant-
based x-3 fatty acid. As recommended by Kris-Etherton
et al. (2003) and Rodriguez et al. (2010), total intakes of
1.5–3.0 g/day of a-linolenic acid by human seem to be
beneﬁcial, especially for treatment and prevention of cardio-
vascular diseases. Such amount could be fulﬁlled by receiving
fat spread containing ﬂaxseed oil at amounts of 20–40,
20–30, 10–20 and 10 g/day of FPB1 (20% total fat), FPB2
(40% total fat), FPB3 (60% total fat) and FPB4 (80% total
fat), respectively.
In conclusion, Flaxseed oil is a valuable source of various
biologically active compounds (essential polyunsaturated fatty
acids) which serve as basis for a number of effective drugs and
prophylactic preparations as well as important nutritional
additives. Flaxseed oil may be utilized as useful therapeutical
safe food for hyperlipidemia through reducing hepatic lipids.
As use of fat spreads enriched with ﬂaxseed oil is considered
as an easy delivery system of long chain omega-3 PUFA in
the human body, using pure ﬂaxseed oil in fat spread formula-
tion can be considered as promise trend in the ﬁeld of thera-
peutical fat spreads. These spreads characterize by relative
high TUFAs content, especially the healthy fatty acid
(omega-3, C18:3) and being free of trans fatty acids with good
sensory properties.References
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